Committee pauses on bill to allow hospitals to dispense unused emergency medications; members raise labeling, scope concerns

The committee discussed Assembly Bill 447 on April 9, 2025, a bill that would allow a prescriber to dispense an unused portion of a dangerous drug from a hospital pharmacy to an emergency room patient under specified conditions and would exempt certain automated drug dispensing systems (ADDS) used for that purpose from licensure under Business and Professions Code section 4066(c)(8).

Why it matters: Supporters said the change could improve patient access to immediate, necessary medications after an emergency visit, and could reduce waste when multi-use items such as inhalers, creams or ointments are already opened. Members and public commenters warned that without clearer labeling and documentation requirements the change could create patient safety risks and compliance gaps.

Members debated access versus safeguards. Maria Serpa, licensee member, said she supports addressing access problems for emergency patients but urged more detail on what “unused portion” means and how hospitals would label and document those items. "The concern comes with … having it be appropriately labeled and having all the information that the patient needs and that it be documented that it was dispensed to the patient by the pharmacy," Serpa said. She described common emergency-room practices — relabeling inhalers or sending items to pharmacy for a relabel — and warned that informal handoffs sometimes leave items without sufficient documentation.

Committee discussion highlighted two recurring issues: whether ADDS used to dispense take-home medications should be exempt from licensure, and whether the bill might unintentionally permit dispensing future doses (for example, a full bottle of antibiotics) rather than only the remaining, already-opened portion. "I think that's going to the definition of unused portion," Serpa said, noting the risk of scope creep if unit-dose future tablets are treated the same as single-patient multi-use items.

Public commenters largely agreed with the committee's caution while supporting the policy goal. Keith Yoshizuka of the California Society of Health System Pharmacists urged prompt amendments addressing labeling and reminded the committee that existing law requires prescription medications dispensed by a prescriber to meet pharmacy labeling requirements. "My fear is that people will look at just that one section … and go ahead and give it out without the proper labeling," Yoshizuka said. Andre Peters, speaking as a pharmacist, said not exempting ADDS from licensure could create a barrier to hospital implementation; he urged an exemption tied to a narrowly defined primary purpose.

Committee action and next steps: After discussion and public comment, the committee elected not to take a formal vote to adopt a position and directed staff to continue monitoring the bill. The item was left at a "watch" status so the committee can review amended language and potential clarifying edits before adopting a formal position.

The committee noted related implementation tasks for staff, including tracking amendments that may address labeling, documentation and the ADDS exemption. The committee’s next full meeting is scheduled for June 11, 2025.